ITOL vs. CANC
ITOL (Tema International Durable Quality ETF) and CANC (Tema Oncology ETF) are both exchange-traded funds - ITOL is a Foreign Large Cap Equities fund actively managed by Tema, while CANC is a Health & Biotech Equities fund actively managed by Tema. Both are actively managed. At a 0.44 correlation, their price movements are largely independent. ITOL charges 0.60%/yr vs 0.75%/yr for CANC.
Performance
ITOL vs. CANC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ITOL achieves a 0.58% return, which is significantly lower than CANC's 4.82% return.
ITOL
- 1D
- 0.00%
- 1M
- 1.19%
- YTD
- 0.58%
- 6M
- 3.05%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CANC
- 1D
- 0.08%
- 1M
- -3.73%
- YTD
- 4.82%
- 6M
- 3.86%
- 1Y
- 47.37%
- 3Y*
- 107.76%
- 5Y*
- —
- 10Y*
- —
ITOL vs. CANC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
ITOL Tema International Durable Quality ETF | 0.58% | 3.85% |
CANC Tema Oncology ETF | 4.82% | 25.08% |
Correlation
The correlation between ITOL and CANC is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Sep 12, 2025 | 0.44 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ITOL vs. CANC — Risk / Return Rank
ITOL
CANC
ITOL vs. CANC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tema International Durable Quality ETF (ITOL) and Tema Oncology ETF (CANC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| ITOL | CANC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 2.06 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.35 | -0.04 | +0.38 |
Drawdowns
ITOL vs. CANC - Drawdown Comparison
The maximum ITOL drawdown since its inception was -15.54%, smaller than the maximum CANC drawdown of -97.53%. Use the drawdown chart below to compare losses from any high point for ITOL and CANC.
Loading charts...
Drawdown Indicators
| ITOL | CANC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -15.54% | -97.53% | +81.99% |
Max Drawdown (1Y)Largest decline over 1 year | — | -8.67% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -30.27% | — |
Current DrawdownCurrent decline from peak | -5.46% | -56.55% | +51.09% |
Average DrawdownAverage peak-to-trough decline | -3.59% | -73.19% | +69.60% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 3.25% | — |
Volatility
ITOL vs. CANC - Volatility Comparison
Loading charts...
Volatility by Period
| ITOL | CANC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 6.26% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 16.69% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 17.90% | 23.11% | -5.21% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.90% | 280.27% | -262.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.90% | 280.27% | -262.37% |
ITOL vs. CANC - Expense Ratio Comparison
ITOL has a 0.60% expense ratio, which is lower than CANC's 0.75% expense ratio.
Dividends
ITOL vs. CANC - Dividend Comparison
ITOL's dividend yield for the trailing twelve months is around 0.13%, more than CANC's 0.05% yield.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
CANC Tema Oncology ETF | 0.05% | 0.06% | 3.00% | 0.56% |
ITOL Tema International Durable Quality ETF | 0.13% | 0.13% | 0.00% | 0.00% |
Frequently Asked Questions
ITOL and CANC have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, ITOL is cheaper at 0.60% per year. The better choice depends on whether you care most about return, fees, risk, or income.
ITOL is cheaper with a 0.60% expense ratio, compared with 0.75% for CANC.
ITOL has the higher dividend yield at 0.13%, compared with 0.05% for CANC.
ITOL is categorized as Foreign Large Cap Equities, while CANC is Health & Biotech Equities. Their fees differ too: 0.60% for ITOL and 0.75% for CANC.
Find the right allocation for ITOL and CANC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer